JournalArta
Wednesday, November 18, 2026 · JakartaS&P 7,303.98 ▼0.50%USD/IDR 18,245 ▼0.09%
JournalArta
Global Edition
beyond headlines
Advertisement

QBE Insurance Share Price Update: Falls 0.64%, Up 1.7% in a Month

Technical analysis of QBE stock on November 18, 2026: price 26.47 AUD, trend uptrend, RSI 58.0, support 25.40, resistance 26.87.

By matthew jonathan
November 18, 20265 min read
QBE Insurance Share Price Update: Falls 0.64%, Up 1.7% in a Month
Logo QBE Insurance Group — JournalArta illustration

Why QBE is in focus today

    Selected automatically from 9 ASX (Australia) stocks by a technical-signal score with daily weighted randomisation — not a recommendation.

    QBE Insurance Group shares slipped 0.64% to 26.47 AUD in the Wednesday, November 18, 2026 session, a modest pullback that nonetheless keeps the insurer's stock within striking distance of its three-month high of 26.96. The move came on lighter-than-usual participation — 2.82 million shares traded against a 20-day average of 3.29 million — which matters less for what it says about selling pressure than for what it says about conviction: few holders were willing to part with stock near the top of the range. The bigger signal sits underneath the daily drift. QBE remains in an uptrend, with the 20-day average at 26.27 sitting above the 50-day average at 24.88, and the price holding above both. The 20-day average itself rose 0.79% over the past five sessions — a measure of the trend's slope, not the stock's return — confirming that the broader drift is upward even as the last week printed a small negative (-0.38%). Over one month the stock is up 1.73%, and it currently trades at 73% of its 20-day range.
    Advertisement

    Trend & Price Action

    The most instructive feature of this setup is the pullback itself. QBE has eased back toward its 20-day average after pressing the 26.87 resistance — the top of its recent range — and that average has acted as a floor rather than a ceiling. A stock that retreats to its rising 20-day line without breaking it is typically consolidating, not reversing. Crucially, no new moving-average crossover has formed; the existing bullish alignment (price above the 20-day, 20-day above the 50-day) is simply being tested.
    Price action chart of QBE
    3-month price action chart of QBE: price, SMA20/50, Bollinger, support & resistance.
    The upper Bollinger band at 27.08 and the 20-day resistance at 26.87 sit almost on top of each other, creating a clear ceiling zone. The three-month high of 26.96 falls inside that band, which tells you the market has twice been turned back near 27 without the structure underneath deteriorating. On the downside, the 20-day support at 25.40 and the lower Bollinger band at 25.46 are effectively the same level — a coincidence that strengthens its significance as a line in the sand.
    Advertisement

    Oscillators & Momentum

    Momentum is where the caution lives. The RSI(14) at 58.0 is squarely neutral, but the code-computed signals flag it as rolling over from above 65 — in plain terms, the buying pressure that pushed the stock higher has cooled. The MACD tells a similar story: at 0.484 it sits below its signal line of 0.536, with a negative histogram of -0.052. That is a short-term momentum loss, not a trend break, but it explains why the stock is drifting rather than advancing.
    Momentum chart of QBE
    Momentum chart of QBE: RSI(14), MACD, Stochastic.
    The Stochastic adds nuance. %K at 65.0 below %D at 80.2 suggests the fast line has turned down from an overbought reading, reinforcing the consolidation narrative. Read together, these three indicators say the same thing: the uptrend is intact, but the immediate push has stalled. That is a pullback within a trend, not a reversal signal — the distinction matters for anyone watching the chart.
    Advertisement

    Volatility & Volume

    The Bollinger bands are narrowing, with a width of 6.2% — a squeeze condition that historically precedes a larger directional move. Paired with an ATR of 0.48, or 1.8% of the price, volatility is moderate: the stock is not coiling violently, but it is coiling. The squeeze resolves in one of two directions, and the surrounding structure — price above both averages, rising OBV — tilts the odds toward an upward resolution. Volume at 0.9 times normal is thin, but OBV is rising, meaning the cumulative volume flow still favors buyers. Thin volume on a down day is far less concerning than thin volume on a rally; it suggests absence of sellers rather than presence of buyers.
    Advertisement

    Key Levels & Scenarios

    The map is unusually clean. A decisive close above 26.87 would open the path toward the Bollinger upper band at 27.08 and, beyond it, the three-month high at 26.96 — though the stock needs to clear the resistance cluster first. Failure to hold 25.40 would break the 20-day support and bring the lower band at 25.46 into play as the next reference, with the 50-day average at 24.88 as the deeper structural floor. The risk case is straightforward: if the RSI continues to roll over and the MACD histogram deepens negative, the consolidation could extend into a deeper test of the 50-day average. But that would require the price to lose the 20-day line first, and nothing in the current data suggests that is imminent.
    Advertisement

    Technical Verdict: BUY

    The verdict is BUY, aligned with the JournalArta research score of +66. Three reasons carry the call: the price sits above its 50-day average at 24.88 with the 20-day average above it — a textbook bullish alignment; the uptrend is confirmed by a rising OBV, showing accumulation beneath the surface; and the RSI at 58.0 remains in the healthy 50–70 zone, leaving room to run without being overbought. - Entry Range: 26.12 – 26.47 - Exit Targets: 28.22 (target 1) and 29.98 (target 2) - Stop Loss: 25.30 - Reward/Risk: 1.5 to 3.0 - Validity: through 16 December 2026 The verdict is invalidated if the price breaks below 25.30, which would undercut the 20-day support zone and question the uptrend structure. In plain English: the trend is up, the stock has paused rather than reversed, and the setup favors buyers as long as it holds above its recent support. This is technical analysis, not investment advice — the site disclaimer applies. The next scheduled event is the 16 December 2026 validity expiry, by which point the narrowing Bollinger squeeze should have resolved in one direction or the other.
    Advertisement

    Summary Data QBE

    Last price26.47 AUD
    Change 1 day / 5 days / 1 month-0.64% / -0.38% / 1.73%
    Trend / MA-crossuptrend / none
    SMA20 / SMA5026.27 / 24.88
    RSI (14) / Stochastic %K58.0 / 65.0
    Bollinger %B / ATR62% / 0.48
    Support / Resistance 20 days25.40 / 26.87
    Data as of18 November 2026 12:10 WIB
    JournalArta research verdict (score)Buy (+66)
    Entry zone26.12 – 26.47
    Target 1 / 228.22 / 29.98
    Stop loss25.30
    Reward/risk1.5 / 3.0

    Disclaimer: This technical analysis is generated automatically from exchange data and indicators calculated by JournalArta, for information and education only. The verdict and the entry, target and stop-loss levels are not investment advice or a solicitation to buy or sell any security. Investment decisions and their risks rest solely with the reader.

    Advertisement
    Take the quizWhat Kind of Holiday Spender Are You? Take the Black Friday QuizStart →
    Advertisement
    Most Read
    1. 1U.S. Emergency Alert Test Nov. 17 Is Not a Power Outage
    2. 2Gold Silver Price November: Futures Rise Near Yearly Lows
    3. 3Michael Clarke Says Sandpapergate Scars Drew Steve Smith to New York
    4. 4GTA 6 New Zealand Time Trick Is Not Guaranteed to Work
    5. 5Sunrise on the Reaping Reviews Split Over Dark Hunger Games Prequel
    Advertisement
    Don't Miss

    Latest News

    All stories →
    1. WorldPutin Attacks Western Sanctions as Trump Arrives in ChinaNov 18
    2. World · EuropeEU Auditors Say Chemical Health Protections Are Too SlowNov 18
    3. Lifestyle · Food & HealthUS Loses Measles Elimination Status After 26 YearsNov 18
    4. Sport · More SportsUtah Mammoth Unveil Winter Classic Jersey for Outdoor DebutNov 18
    5. Advertisement
    6. Sport · More SportsMariners’ Randy Arozarena Rejects Qualifying Offer, Enters Free AgencyNov 18
    7. Technology · AIUK MHRA Launches AdvanceGxP to Speed Up AI and Hospital-Made MedicinesNov 18
    8. Lifestyle · EntertainmentFeige Says Marvel Planned Doctor Doom Before Majors ConvictionNov 18
    9. Lifestyle · Food & HealthResearchers Say Most Children Labeled Allergic to Penicillin Are NotNov 18